# OnCo record nct05623267 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05623267/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05623267", "NCT05623267" ;
  schema:name "Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT"@en ;
  schema:alternateName "SURPASS"@en ;
  schema:description "A phase 2/3 trial of sugemalimab in lung cancer, run by Sun Yat-sen University, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05623267/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05623267> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest", "lung-deep-dive" ;
  onco:phase "2/3" ;
  onco:cancers <https://onco.cc/cancers/limited-stage-sclc/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/imrt-igrt/> ;
  onco:drugs <https://onco.cc/drugs/sugemalimab/> .